Literature DB >> 18550936

Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors.

John P Forman1, Naomi D L Fisher, Martin R Pollak, David G Cox, Stephan Tonna, Gary C Curhan.   

Abstract

Renin-angiotensin system (RAS) polymorphisms have been studied as candidate risk factors for hypertension with inconsistent results, possibly due to heterogeneity among various environmental factors. We analyzed the association between RAS candidate gene polymorphisms and risk of hypertension among 2722 women and also explored whether these associations varied according to menopausal status, body mass index, and dietary factors. In a main-effects analysis of all 2722 women adjusted for age and race, homozygosity for the AT1R A1166C polymorphism was associated with hypertension (odds ratio, 1.35; 95% confidence interval [CI], 1.03-1.78). We also found that a novel nonsense polymorphism in the aminopeptidase-A gene was associated with hypertension among postmenopausal women (hazard ratio, 1.54; 95% CI, 1.01-2.37), women with inadequate calcium intake (hazard ratio, 2.47; 95% CI, 1.29-4.72) and, marginally, women with inadequate vitamin D intake. In addition, angiotensin-converting enzyme and AT1R A1166C polymorphisms were associated or marginally associated with incident hypertension among postmenopausal women and those with inadequate calcium and vitamin D intakes. These data suggest that demographic and dietary factors may influence the associations between RAS polymorphisms and hypertension and could explain heterogeneity in prior studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550936      PMCID: PMC8109873          DOI: 10.1111/j.1751-7176.2008.08007.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  48 in total

1.  Epidemiological evidence of an interaction between calcium and sodium intake impacting on blood pressure. A Montréal study.

Authors:  P Hamet; M Daignault-Gélinas; J Lambert; M Ledoux; L Whissell-Cambiotti; F Bellavance; E Mongeau
Journal:  Am J Hypertens       Date:  1992-06       Impact factor: 2.689

2.  The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk.

Authors:  J A Staessen; J G Wang; G Ginocchio; V Petrov; A P Saavedra; F Soubrier; R Vlietinck; R Fagard
Journal:  J Hypertens       Date:  1997-12       Impact factor: 4.844

3.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.

Authors:  M Pfeifer; B Begerow; H W Minne; D Nachtigall; C Hansen
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

Review 4.  Genetics of human hypertension.

Authors:  Anupam Agarwal; Gordon H Williams; Naomi D L Fisher
Journal:  Trends Endocrinol Metab       Date:  2005-04       Impact factor: 12.015

5.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials.

Authors:  P K Whelton; J He; J A Cutler; F L Brancati; L J Appel; D Follmann; M J Klag
Journal:  JAMA       Date:  1997-05-28       Impact factor: 56.272

Review 6.  Overview of general physiologic features and functions of vitamin D.

Authors:  Hector F DeLuca
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

7.  Surgical menopause increases salt sensitivity of blood pressure.

Authors:  Ivonne Hernandez Schulman; Pedro Aranda; Leopoldo Raij; Maddalena Veronesi; Francisco J Aranda; Remedios Martin
Journal:  Hypertension       Date:  2006-04-17       Impact factor: 10.190

8.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Authors:  Yan Chun Li; Juan Kong; Minjie Wei; Zhou-Feng Chen; Shu Q Liu; Li-Ping Cao
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  A prospective study of high blood pressure and cardiovascular disease in women.

Authors:  N H Fiebach; P R Hebert; M J Stampfer; G A Colditz; W C Willett; B Rosner; F E Speizer; C H Hennekens
Journal:  Am J Epidemiol       Date:  1989-10       Impact factor: 4.897

10.  Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women.

Authors:  G A Colditz; P Martin; M J Stampfer; W C Willett; L Sampson; B Rosner; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1986-05       Impact factor: 4.897

View more
  4 in total

1.  Chromosome 2 Fragment Substitutions in Dahl Salt-Sensitive Rats and RNA Sequencing Identified Enpep and Hs2st1 as Vascular Inflammatory Modulators.

Authors:  Olga Berillo; Sofiane Ouerd; Noureddine Idris-Khodja; Asia Rehman; Chantal Richer; Daniel Sinnett; Anne E Kwitek; Pierre Paradis; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2020-11-09       Impact factor: 10.190

2.  Gender specific association of RAS gene polymorphism with essential hypertension: a case-control study.

Authors:  Kh Dhanachandra Singh; Ajay Jajodia; Harpreet Kaur; Ritushree Kukreti; Muthusamy Karthikeyan
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

Review 3.  Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation.

Authors:  Santiago Cuevas; Van Anthony M Villar; Pedro A Jose
Journal:  Pharmacogenomics J       Date:  2019-02-06       Impact factor: 3.550

4.  Mammalian Glutamyl Aminopeptidase Genes (ENPEP) and Proteins: Comparative Studies of a Major Contributor to Arterial Hypertension.

Authors:  Roger S Holmes; Kimberly D Spradling-Reeves; Laura A Cox
Journal:  J Data Mining Genomics Proteomics       Date:  2017-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.